alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
PEMCO-01252016-00004

l®® ° ~ ~1 affi ~~~ Date: January 24, 2016 Federal Aviation Administration (FAA) RE: Petition for an Amendment to Exemption 8625 Refererences: /A/ Regulatory Docket No. 2005-22869 Exemption 8625 /B/ FAA Project No. SA15076AT-T 

### Dear FAA, Pemco World Air Services request relief from regulations:
1. 14 CFR 25.785(j) Amendment 25-88 2. 14 CFR 25.855(a) Amendment 25-93 3. 14 CFR 25.857(e) Amendment 25-93 4. 14 CFR 25.1447(c)(1) Amendment 25-87 5. 14 CFR 121.583(a) Pemco is requesting an amendment to the current exemption 8625 to permit carriage of 2 

### additional non-crew persons on an all-freighter airplane. This request would change the current restriction of 2 non-crew members to 4 non-crew members. Pemco notes that precautions and instructions for the current Exemption 8625 has not changed for the existing 2 non-crew members. The oxygen supply and associated instructions and 

### warning including signs and notifications are the same as described in Exemption 8625 for 2 noncrew members. For the 2 additional non-crew members in the vestibule, the associated instructions and warnings are identical to the B737-400. Oxygen supply in case of depressurization is ensured by portable oxygen bottles installed directly adjacent to the double flight attendant seat (supernumerary). Portable oxygen mask are connected to the high pressure outlet. When oxygen masks need to be used, occupants are notified by a chime and by lighted signs located within view. Activation of signs have not changed. The original Supporting Argument of Exemption 8625 also applies to the this petition for amendment. 

### Sinc rely,

Victor Burnett Director of Engineering Pemco World Air Services, Inc 4102 N. Westshore Blvd. Tampa, FL 33614 Phone: 813-322-9637 Mobile: 334-791-9601 Email: victor.burnett@pemcoair.com PAGE 1 OF 1

4102 N. WESTSHORE BLVD ® TAMPA, FL 33614 • PHONE (813) 322-9600
Case: 3:18-mj-00162-SLO Doc #: 4 Filed: 03/02/18 Page: 1 of 2 PAGEID #: 57
Case: 3:18-mj-00162-SLO Doc #: 4 Filed: 03/02/18 Page: 2 of 2 PAGEID #: 58
Exhibit 10.3

EMPLOYMENT AGREEMENT AMENDMENT

This Amendment to the Employment Agreement between Da-Lite Screen Company, Inc., an Indiana corporation (the Company), and
Richard E. Lundin (the Executive) is dated as of July 30, 2010.

WHEREAS, the Company and the Executive
desire to amend certain provisions of the Executives Employment Agreement dated as of April 5, 2004, as thereafter amended (the Employment Agreement).

NOW, THEREFORE, in consideration of the premises and the mutual agreements contained herein, the Company and Executive hereby agree as
follows:



| | 1. | The term of employment of the Executive provided for in Section 1 of the Employment Agreement shall end on December 31,2015, unless earlier terminated
pursuant to Section 4 of the Employment Agreement.
| | -- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2. | The cash compensation provided for in Section 3(a) of the Employment Agreement shall be increased from $450,000 per year to $465,000 per year, beginning
August 1, 2011. All other provisions of Section 3(a) shall remain unchanged.
| | -- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 3. | Sections 3(b) through 3(d) of the Employment Agreement, and all references thereto, shall be renumbered as Sections 3(c) through 3(e), respectively, and the following
new Section 3(b) shall be added to the Employment Agreement:
| | -- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

(b) Annual Bonuses. For each of the
fiscal years during the Employment Period, the Executive shall be eligible for an annual performance bonus in an amount and subject to the attainment of performance objectives (if any) determined by the Board in its sole discretion.

All of the provisions of the Employment Agreement not amended hereby shall remain in full force and effect.

IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date written above.



|                             |  |                           |  |  |  |                      
|---------------------------- |  | ------------------------- |  |  |  | ---------------------
|Da-Lite Screen Company, Inc.
|                             |  |                           | 
|By:                          |  | /s/ Jerry C. Young        |  |  |  | /s/ Richard E. Lundin
|Title:                       |  | Vice President of Finance |  |  |  | Richard E. Lundin
Case: 3:18-cr-00073-TMR Doc #: 10 Filed: 05/22/18 Page: 1 of 17 PAGEID #: 34
Case: 3:18-cr-00073-TMR Doc #: 10 Filed: 05/22/18 Page: 2 of 17 PAGEID #: 35
Case: 3:18-cr-00073-TMR Doc #: 10 Filed: 05/22/18 Page: 3 of 17 PAGEID #: 36
Case: 3:18-cr-00073-TMR Doc #: 10 Filed: 05/22/18 Page: 4 of 17 PAGEID #: 37
Case: 3:18-cr-00073-TMR Doc #: 10 Filed: 05/22/18 Page: 5 of 17 PAGEID #: 38
Case: 3:18-cr-00073-TMR Doc #: 10 Filed: 05/22/18 Page: 6 of 17 PAGEID #: 39
Case: 3:18-cr-00073-TMR Doc #: 10 Filed: 05/22/18 Page: 7 of 17 PAGEID #: 40
Case: 3:18-cr-00073-TMR Doc #: 10 Filed: 05/22/18 Page: 8 of 17 PAGEID #: 41
Case: 3:18-cr-00073-TMR Doc #: 10 Filed: 05/22/18 Page: 9 of 17 PAGEID #: 42
Case: 3:18-cr-00073-TMR Doc #: 10 Filed: 05/22/18 Page: 10 of 17 PAGEID #: 43
Case: 3:18-cr-00073-TMR Doc #: 10 Filed: 05/22/18 Page: 11 of 17 PAGEID #: 44
Case: 3:18-cr-00073-TMR Doc #: 10 Filed: 05/22/18 Page: 12 of 17 PAGEID #: 45
Case: 3:18-cr-00073-TMR Doc #: 10 Filed: 05/22/18 Page: 13 of 17 PAGEID #: 46
Case: 3:18-cr-00073-TMR Doc #: 10 Filed: 05/22/18 Page: 14 of 17 PAGEID #: 47
Case: 3:18-cr-00073-TMR Doc #: 10 Filed: 05/22/18 Page: 15 of 17 PAGEID #: 48
Case: 3:18-cr-00073-TMR Doc #: 10 Filed: 05/22/18 Page: 16 of 17 PAGEID #: 49
Case: 3:18-cr-00073-TMR Doc #: 10 Filed: 05/22/18 Page: 17 of 17 PAGEID #: 50
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Dental and Craniofacial Research Special Emphasis Panel; Clinical Studies.                    

*Date:*                         February 23, 2022.                    

*Time:*                         9:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications and/or proposals.                    

*Place:*                         National Institute of Dental and Craniofacial Research, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Yun Mei, MD Scientific Review Officer, Scientific Review Branch, Natl Institute of Dental and Craniofacial Research, National Institutes of Health, 6701 Democracy Boulevard, Suite #670, Bethesda, MD 20892, (301) 827-4639,                         *yun.mei@nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program No. 93.121, Oral Diseases and Disorders Research, National Institutes of Health, HHS)

Dated: January 18, 2022. 

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2022-01201 Filed 1-21-22; 8:45 am]

BILLING CODE 4140-01-P
**EXHIBIT      32.1**

**CERTIFICATION      OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO**

**RULE      13a-14(b)/15d-14(b) OF THE SECURITIES EXCHANGE ACT OF 1934      AND**

**18      U.S.C. SECTION 1350**

|   | (1) | The                Report fully complies with the requirements of Section 13(a) or 15(d)                of                the Securities Exchange Act of 1934;                and |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | The                information contained in the Report fairly presents, in all material                respects, the financial condition and results of operations of the                Company. |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                                       |                                                                                  |                              |
|--------------------------------------------|---------------------------------------------------------------------------------------|-----------------------------------|
| Date: October                26, 2007 |                                                                             | /s/                Seung Kwon Noh |
|                                       | Seung                Kwon NohPresident                  & Chief Executive Officer |
|                                       | (Principal                Executive Officer)                                          |

----
EX-10.8



 Exhibit 10.8 

AMENDMENT NO. 1 
 TO THE

 IGLOO HOLDINGS CORPORATION 

2010 STOCK INCENTIVE PLAN 

This Amendment No. 1 (the “Amendment”) to the Igloo Holdings Corporation 2010 Stock Incentive Plan (the
“Plan”) is made effective as of this 15th day of September 2010. 

WHEREAS, Igloo Holdings Corporation (the “Company”) maintains the Plan; and 

WHEREAS, pursuant to Section 17 of the Plan, the Plan may be amended by the Company’s Board of Directors
(the “Board”); and 
 WHEREAS, the Board believes it to be in the best interests of the Company to amend the Plan as
set forth herein. 
 NOW, THEREFORE, the Plan is hereby amended as follows: 

1. By restating the definition of “Permitted Transfer” in Section 2(y) as follows: 

““Permitted Transfer” means any transfer by a Participant of all or any portion of his shares of Stock (or Options, for
purposes of Section 5(f) below) to (i) any trust established for the sole benefit of such Participant or such Participant’s spouse, direct lineal descendents, or brothers- or sisters-in-law, provided such Participant is the
sole trustee of such trust, (ii) any other entity (including an Individual Retirement Account or similar investment account) in which the direct and beneficial owner of all voting securities of such entity is held by such Participant, or
(iii) such Participant’s heirs, executors, administrators, or personal representatives upon the death of such Participant.” 

2. By restating Section 5(f) in its entirety as follows: 

“Transferability of Options. Except in connection with a Permitted Transfer of Options, an Option shall not be transferable except
by will or by the laws of descent and distribution and shall be exercisable during the lifetime of the Participant only by the Participant. To the extent a Participant wishes to make a Permitted Transfer of Options, it shall be a condition of each
such Permitted Transfer that (x) the transferee agrees to be bound by the terms of the Plan and the applicable Award agreement as though no such transfer had taken place, and (y) the Participant has complied with all applicable law in
connection with such transfer. The Participant and the transferee shall execute any documents reasonably required by the Committee to effectuate such Permitted Transfer.” 







 Except as modified by this Amendment, all of the terms and conditions of the Plan shall remain
valid and in full force and effect. 
 *        *        *

 [Remainder of page intentionally left blank.] 

  
 - 2 - 








 IN WITNESS WHEREOF, the undersigned, a duly authorized officer of the Company, has executed this
instrument as of the 15th day of September 2010, on behalf of the Board. 
  

			
	IGLOO HOLDINGS CORPORATION
		
	By:	 	 /s/ Mason Slaine

	Name:	 	Mason Slaine
	Title:	 	Chairman


 [Signature Page to Amendment 1 to Stock Incentive Plan]
Exhibit
32.1





CERTIFICATION
OF CHIEF EXECUTIVE OFFICER





Pursuant to 18 U.S.C. Section1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, the undersigned
officer of Subjex Corporation does hereby certifythat:





(a) the Quarterly Report on Form 10-Q of Subjex
Corporation for thenone months and three
monthsended September 30, 2008(the “Report”) fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
and





(b) information contained in the Report fairly presents,
in all material respects,the financial
conditionand results of operations of
Subjex Corporation





Date:
      November 7, 2008
                        By:
                        /s/ Andrew D. HyderAndrew D. HyderPresident& Chief Executive
    Officer
[Federal Register Volume 87, Number 14 (Friday, January 21, 2022)]
[Notices]
[Page 3298]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01149]


-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[ER-FRL-9060-4]


Environmental Impact Statements; Notice of Availability

    Responsible Agency: Office of Federal Activities, General 
Information 202-564-5632 or https://www.epa.gov/nepa.

Weekly receipt of Environmental Impact Statements (EIS)
Filed January 10, 2022 10 a.m. EST Through January 14, 2022 10 a.m. EST
Pursuant to 40 CFR 1506.9.

    Notice: Section 309(a) of the Clean Air Act requires that EPA make 
public its comments on EISs issued by other Federal agencies. EPA's 
comment letters on EISs are available at: https://cdxnodengn.epa.gov/cdx-enepa-public/action/eis/search.

EIS No. 20220006, Final, NMFS, ME, Amendment 23 to the Northeast 
Multispecies Fishery Management Plan, Review Period Ends: 02/22/2022, 
Contact: Mark Grant 978-281-9145.

Amended Notice

EIS No. 20210179, Draft, Caltrans, CA, Cajalco Road Widening and Safety 
Enhancement Project, Comment Period Ends: 03/03/2022, Contact: Aaron 
Burton 909-383-2841. Revision to FR Notice Published 12/03/2021; 
Extending the Comment Period from 01/18/2022 to 03/03/2022.

    Dated: January 14, 2022.
Cindy S. Barger,
Director, NEPA Compliance Division, Office of Federal Activities.
[FR Doc. 2022-01149 Filed 1-20-22; 8:45 am]
BILLING CODE 6560-50-P
AO 450 (Rev. 11/11) Judgment in a Civil Action

UNITED STATES DISTRICT COURT

for the

__________ District of __________

)

)

)

)

)

Plaintiff

v. Civil Action No.

Defendant

JUDGMENT IN A CIVIL ACTION

The court has ordered that (check one):

u the plaintiff (name) recover from the

defendant (name) the amount of

dollars ($ ), which includes prejudgment

interest at the rate of %, plus post judgment interest at the rate of % per annum, along with costs.

u the plaintiff recover nothing, the action be dismissed on the merits, and the defendant (name)

recover costs from the plaintiff (name)

.

u other:

.

This action was (check one):

u tried by a jury with Judge presiding, and the jury has

rendered a verdict.

u tried by Judge without a jury and the above decision

was reached.

u decided by Judge on a motion for

.

Date: CLERK OF COURT

Signature of Clerk or Deputy Clerk

6/10/19

 Southern District of Ohio

LEONE D. MEBANE

3:18-cv-90

Commissioner of Social Security

✔ the Commissioner’s non-disability finding is unsupported by substantial evidence, and REVERSED; (2) this

matter is REMANDED to the Commissioner under the Fourth Sentence of 42 U.S.C. § 405(g)

✔ Sharon L. Ovington

Decision and Order
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Microbiology, Infectious Diseases and AIDS Initial Review Group; Microbiology and Infectious Diseases B Research Study Section.                    

*Date:*                         February 28-March 2, 2022.                    

*Time:*                         11:00 a.m. to 5:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F30, Rockville, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Mario Cerritelli, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F58, Rockville, MD 20852, 240-669-5199,                         *cerritem@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: January 21, 2022.

Tyeshia M. Roberson-Curtis,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2022-01549 Filed 1-26-22; 8:45 am]

BILLING CODE 4140-01-P
THE UNITED STATES DISTRICT COURT

FOR THE SOUTHERN DISTRICT OF OHIO

WESTERN DIVISION AT DAYTON

UNITED STATES OF

AMERICA,

Plaintiff,

Case No. 3:18-cr-65

V. '

DAMONE ALEXANDER, Judge Walter H. Rice

Defendant. •

ORDER OVERRULING MOTION FOR COMPASSIONATE RELEASE OF

DEFENDANT DAMONE ALEXANDER (DOC. #51) AS MOOT GIVEN

DEFENDANT IS NO LONGER INCARCERATED

Before the Court is the Motion for Compassionate Release of Defendant

Damone Alexander. (Doc. #51). On March 3, 2020, Defendant was sentenced to

ninety-six months imprisonment after pleading guilty to one count from the

Indictment. (Judgment, Doc. #45, citing Indictment, Doc. #19). On December 8,

2020, Defendant filed the Motion under 18 U.S.C. § 3582(c)(1)(A), as amended

by the Formerly Incarcerated Reenter Society Transformed Safely Transitioning

Every Person Act ("First Step") Act of 2018, Pub. L. 115-391, 132 Stat. 5194.

While the Motion was pending. Defendant was released on March 14, 2024.^ A

case becomes moot if "the issues presented are no longer 'live' or the parties lack

a legally cognizable interest in the outcome." Murphy v. Hunt, 455 U.S. 478, 481

(1984) (citation omitted). A motion for compassionate release seeks relief not

^ https://www.bop.gov/mobile/flndJnmate/index.jsp#inmate_results (last accessed Jun. 28, 2024).

Case: 3:18-cr-00065-WHR Doc #: 56 Filed: 06/28/24 Page: 1 of 2 PAGEID #: 362
from the judgment in toto, but from the confinement imposed as part of the

judgment. "When a prisoner is released from custody, the motion for

compassionate release becomes moot because there is no further relief this Court

can provide!,]" United States v. Sanchez, No. 16-cr-2077, 2021 WL 5999764, *1

(S.D. Gal. Dec. 17, 2021) (collecting cases), and there is no longer a "live" and

redressable issue pending before the Court. See, e.g., United States v. Hernandez,

845 F. App'x 921, 921 (11th Cir. 2021) (per curiam) ("Completion of a prison

term moots a challenge to the term of confinement.").

As Defendant has completed his term of confinement, his Motion no longer

presents a live case or controversy, and the Court is without jurisdiction to hear it.

U.S. Const, art. Ill § 2. Accordingly, the Motion is OVERRULED AS MOOT.^

The captioned case remains terminated upon the docket records of the

United States District Court for the Southern District of Ohio, Western Division, at

Dayton.

IT IS SO ORDERED.

(/.

WALTER H. RICE, JUDGE

June 28, 2024 UNITED STATES DISTRICT COURT

^ Also, the Court, having considered the factors for granting compassionate release set forth in

United States v. Tomes. 990 F.3d 500, 502 {6th Cir. 2021), concludes that Defendant would not

have been eligible for release while he was incarcerated, as Defendant did not specify in his Motion

any health or other factors that would have made him unusually susceptible to contracting COVID19. [See, e.g., Warden Resp., Doc. #51, PAGEID 348).

Case: 3:18-cr-00065-WHR Doc #: 56 Filed: 06/28/24 Page: 2 of 2 PAGEID #: 363